Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients
A Phase II Study of Microtransplantation in Patients With Refractory or Relapsed Hematologic Malignancies
Sponsor: Cookies for Kids' Cancer
Terminated
The study was closed due to poor accrual and because of competing protocols.
Other Acute Myeloid Leukemia (AML) trials with similar outcome
This PHASE2 trial investigates Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) and is currently terminated or withdrawn. Cookies for Kids' Cancer leads this study, which shows 10 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Nov 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jun 2017 — Nov 2017 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE2
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cookies for Kids' Cancer
- St. Jude Children's Research Hospital
For direct contact, visit the study record on ClinicalTrials.gov .